Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF)
Charles Comiter, Eeshit Dhaval Vaishnav, Metamia Ciampricotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D
Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, et al.
Cancer Immunology Research
|
September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer
Brandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 7, 2022
Precision spinal gene delivery-induced functional switch in nociceptive neurons reverses neuropathic pain
Takahiro Tadokoro, Mariana Bravo-Hernandez, Kirill Agashkov, et al.
Gynecologic Oncology
|
May 20, 2025
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer
Elizabeth K Lee, Niya Xiong, Carolyn Krasner, et al.
Heliyon
|
February 6, 2024
Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis
Calum Harvey, Marcel Weinreich, James A K Lee, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Nature Medicine
|
December 25, 2019
Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
Mariana Bravo-Hernandez, Takahiro Tadokoro, Michael R Navarro, et al.
JTO Clinical and Research Reports
|
October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab
Biagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
Science Translational Medicine
|
May 11, 2018
Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs
Jan Strnadel, Cassiano Carromeu, Cedric Bardy, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF)
Charles Comiter, Eeshit Dhaval Vaishnav, Metamia Ciampricotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D
Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, et al.
Cancer Immunology Research
|
September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer
Brandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 7, 2022
Precision spinal gene delivery-induced functional switch in nociceptive neurons reverses neuropathic pain
Takahiro Tadokoro, Mariana Bravo-Hernandez, Kirill Agashkov, et al.
Gynecologic Oncology
|
May 20, 2025
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer
Elizabeth K Lee, Niya Xiong, Carolyn Krasner, et al.
Heliyon
|
February 6, 2024
Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis
Calum Harvey, Marcel Weinreich, James A K Lee, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Nature Medicine
|
December 25, 2019
Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
Mariana Bravo-Hernandez, Takahiro Tadokoro, Michael R Navarro, et al.
JTO Clinical and Research Reports
|
October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab
Biagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
Science Translational Medicine
|
May 11, 2018
Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs
Jan Strnadel, Cassiano Carromeu, Cedric Bardy, et al.
Page
of 21